(Q57240765)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9847254%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

editorial

0 references

title

Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? Yes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9847254%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9847254%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

Israel E

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9847254%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

English

0 references

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9847254%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

7 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9847254%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

158

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9847254%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9847254%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

1697-1698

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9847254%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.6.15860

Leukotriene modifiers in the treatment of asthma. Look promising across the board of asthma severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.6.15860

Antileukotrienes in the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.6.15860

Leukotriene antagonists and synthesis inhibitors: new directions in asthma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.6.15860

Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.6.15860

Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.6.15860

Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.6.15860

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM.158.6.15860

10.1164/AJRCCM.158.6.15860

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9847254%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference